早期阿尔茨海默病中神经炎症与脑血管功能障碍的脑脊液生物标志物
本研究基于瑞典BioFINDER纵向队列,纳入认知未受损老年人508例、轻度认知障碍患者256例和阿尔茨海默病痴呆患者57例,检测脑脊液中反映小胶质细胞和星形胶质细胞活化、神经炎症及脑血管变化的生物标志物。结果显示YKL-40、ICAM-1、VCAM-1、IL-15和Flt-1在AD临床前、前驱期和痴呆期均升高,且与tau升高、皮层变薄及认知下降相关;YKL-40、ICAM-1和Flt-1升高增加无痴呆患者发展为AD痴呆的风险。结论认为神经炎症和脑血管功能障碍是AD症状前阶段即已发生的早期事件,并促进疾病进展。
要点
- 脑脊液YKL-40、ICAM-1、VCAM-1、IL-15和Flt-1在AD临床前、前驱期和痴呆期均升高。
- 这些标志物高水平与脑脊液总tau升高相关,在Aβ阳性个体中关联更强,尤其YKL-40。
- 标志物高水平与皮层变薄及无痴呆患者后续认知下降相关,YKL-40、ICAM-1和Flt-1升高增加AD痴呆风险。
核心结论
- 神经炎症和脑血管功能障碍是AD症状前阶段即已发生的早期事件,并促进疾病进展。
研究设计与样本
- 研究纳入瑞典BioFINDER纵向队列中认知未受损老年人508例、轻度认知障碍患者256例和AD痴呆患者57例,检测脑脊液YKL-40、IL-6、IL-7、IL-8、IL-15、IP-10、单核细胞趋化蛋白1、ICAM-1、VCAM-1、胎盘生长因子和Flt-1,677名参与者有MRI数据,对照和MCI患者进行纵向临床评估(平均随访3年,范围1-6年)。
主要发现
- 脑脊液YKL-40、ICAM-1、VCAM-1、IL-15和Flt-1在AD临床前、前驱期和痴呆期升高。
- 这些标志物高水平与脑脊液总tau升高相关,在Aβ阳性个体中关联更强,尤其YKL-40;磷酸化tau与YKL-40、ICAM-1和VCAM-1的关联类似。
- 标志物高水平与皮层变薄(主要在楔前叶和上顶叶区域)相关,并与无痴呆患者后续认知下降相关,用简易精神状态检查(YKL-40)和临床痴呆评定量表总和框(YKL-40、ICAM-1、VCAM-1和IL-15)衡量。
- 脑脊液YKL-40、ICAM-1和Flt-1较高水平增加无痴呆患者发展为AD痴呆的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To measure CSF levels of biomarkers reflecting microglia and astrocytes activation, neuroinflammation, and cerebrovascular changes and study their associations with the core biomarkers of Alzheimer disease (AD) pathology (β-amyloid [Aβ] and tau), structural imaging correlates, and clinical disease progression over time. METHODS: The study included cognitively unimpaired elderly (n = 508), patients with mild cognitive impairment (MCI, n = 256), and patients with AD dementia (n = 57) from the longitudinal Swedish BioFINDER cohort. CSF samples were analyzed for YKL-40, interleukin (IL)-6, IL-7, IL-8, IL-15, IP-10, monocyte chemoattractant protein 1, intercellular adhesion molecule 1 (ICAM-1), vascular adhesion molecule 1 (VCAM-1), placental growth factor, and fms-related tyrosine kinase 1 (Flt-1). MRI data were available from 677 study participants. Longitudinal clinical assessments were conducted in control individuals and patients with MCI (mean follow-up 3 years, range 1-6 years). RESULTS: CSF levels of YKL-40, ICAM-1, VCAM-1, IL-15, and Flt-1 were increased during the preclinical, prodromal, and dementia stages of AD. High levels of these biomarkers were associated with increased CSF levels of total tau, with the associations, especially for YKL-40, being stronger in Aβ-positive individuals. The results were similar for associations between phosphorylated tau and YKL-40, ICAM-1, and VCAM-1. High levels of the biomarkers were also associated with cortical thinning (primarily in the precuneus and superior parietal regions) and with subsequent cognitive deterioration in patients without dementia as measured with Mini-Mental State Examination (YKL-40) and Clinical Dementia Rating Sum of Boxes (YKL-40, ICAM-1, VCAM-1 and IL-15). Finally, higher levels of CSF YKL-40, ICAM-1, and Flt-1 increased risk of development of AD dementia in patients without dementia. CONCLUSIONS: Neuroinflammation and cerebrovascular dysfunction are early events occurring already at presymptomatic stages of AD and contribute to disease progression.
引用
- Janelidze S, Mattsson N, Stomrud E, et al. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease. Neurology. 2018. PMID: 30054439. doi:10.1212/WNL.0000000000006082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。